Table 4. Comorbidities and Concurrent Medications in Patients With and Without Bleeding.
| Bleeding |
P | ||
|---|---|---|---|
| Present (n = 32) |
Absent (n = 64) |
||
| n (%) | n (%) | ||
| Comorbidity | |||
| Hypertension | 26 (81.3) | 46 (71.9) | 0.317 |
| Heart disease | 15 (46.9) | 32 (50.0) | 0.773 |
| Diabetes | 11 (34.4) | 18 (28.1) | 0.530 |
| Chronic obstructive pulmonary disease | 3 (9.4) | 10 (15.6) | 0.534 |
| Cerebrovascular disease | 2 (6.3) | 9 (14.1) | 0.327 |
| Chronic kidney insufficiency | 1 (3.1) | 7 (10.9) | 0.262 |
| Chronic liver disease | 0 (0) | 1 (1.6) | - |
| Malignancy | 1 (3.1) | 0 (0) | - |
| Concurrent medication | |||
| Antidepressants | 5 (15.6) | 12 (18.8) | 0.705 |
| Acetylsalicylic acid | 5 (15.6) | 7 (10.9) | 0.513 |
| Allopurinol | 3 (9.4) | 7 (10.9) | 1.000 |
| Metformin | 6 (18.8) | 4 (6.3) | 0.079 |
| Lipid-lowering drugs | 5 (15.6) | 4 (6.3) | 0.155 |
| Antibiotic | 4 (12.5) | 4 (6.3) | 0.434 |
| Levothyroxine | 4 (12.5) | 2 (3.1) | 0.093 |
| Antiepileptic | 2 (6.3) | 4 (6.3) | 1.000 |
| Non-steroidal anti-inflammatory drugs | 1 (3.1) | 2 (3.1) | - |
| Low molecular-weight heparin | 1 (3.1) | 1 (1.6) | - |
| Clopidogrel | 0 (0) | 2 (3.1) | - |